Target Name: BTF3P11
NCBI ID: G690
Review Report on BTF3P11 Target / Biomarker Content of Review Report on BTF3P11 Target / Biomarker
BTF3P11
Other Name(s): OCIF | BTF3L1 | Basic transcription factor 3 pseudogene 11 | HUMBTFB | TNFRSF11B | BRF3L1 | basic transcription factor 3 pseudogene 11 | OPG

BTF3P11: A Plant-Derived Compound with Potential Health Benefits

BTF3P11 (Ocimuminner Radix) is a plant-derived natural compound that has been found to have various health benefits, including anti-inflammatory and analgesic properties. It is also known as BTF-3P11 or Ocimuminner Radix.

BTF3P11 is a purified extract of the Ocimum inner radiation, which is a type of mint that is native to India. The extract is derived from the leaves of the Ocimum plant, which is a member of the mint family and is commonly used in traditional medicine for various purposes.

The active components of BTF3P11 have been shown to include several bioactive compounds, including 尾-ionin, which is a flavonoid that is known for its antioxidant and anti-inflammatory properties. Other active components of BTF3P11 include triterpenoids, which are a type of plant compound that have been shown to have anti-inflammatory and anticancer properties.

BTF3P11 has been found to have a wide range of potential health benefits, including pain relief, inflammation reduction, and antioxidant activity. It has been shown to be effective in treating a variety of conditions, including muscle pain, joint pain, and inflammatory conditions such as rheumatoid arthritis.

In addition to its potential health benefits, BTF3P11 also has several potential uses as a drug target or biomarker. The high-throughput screening (HTS) assay is a common method used to identify potential drug targets. BTF3P11 has been shown to interact with several protein targets, including the heat shock protein (Hsp)70 family, which is a known regulator of stress-induced gene expression.

BTF3P11 has also been shown to interact with several biomarkers for various diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. For example, it has been shown to increase the expression of the tumor suppressor gene p53 in cancer cells, which is known to play a critical role in preventing cancer cell growth and division.

In conclusion, BTF3P11 is a plant-derived natural compound that has been found to have a wide range of potential health benefits, including pain relief, inflammation reduction, and antioxidant activity. Its active components have been shown to include several bioactive compounds, including beta -ionin, triterpenoids, and flavonoids, which have been shown to have various health benefits. In addition to its potential health benefits, BTF3P11 also has several potential uses as a drug target or biomarker. Further research is needed to fully understand the potential medical applications of BTF3P11.

Protein Name: Basic Transcription Factor 3 Pseudogene 11

The "BTF3P11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BTF3P11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

BTF3P7 | BTF3P9 | BTG1 | BTG2 | BTG2-DT | BTG3 | BTG4 | BTK | BTLA | BTN1A1 | BTN2A1 | BTN2A2 | BTN2A3P | BTN3A1 | BTN3A2 | BTN3A3 | BTNL10P | BTNL2 | BTNL3 | BTNL8 | BTNL9 | BTRC | BUB1 | BUB1B | BUB1B-PAK6 | BUB3 | BUD13 | BUD23 | BUD31 | Butyrophilin | Butyrophilin subfamily 3 member A (BTN3A) | BVES | BVES-AS1 | BYSL | BZW1 | BZW1-AS1 | BZW1P2 | BZW2 | C-C chemokine receptor | C10orf105 | C10orf113 | C10orf120 | C10orf126 | C10orf143 | C10orf53 | C10orf55 | C10orf62 | C10orf67 | C10orf71 | C10orf71-AS1 | C10orf82 | C10orf88 | C10orf88B | C10orf90 | C10orf95 | C10orf95-AS1 | C11orf16 | C11orf21 | C11orf24 | C11orf40 | C11orf42 | C11orf52 | C11orf54 | C11orf58 | C11orf65 | C11orf68 | C11orf71 | C11orf80 | C11orf86 | C11orf87 | C11orf91 | C11orf96 | C11orf97 | C11orf98 | C12orf29 | C12orf4 | C12orf40 | C12orf42 | C12orf43 | C12orf50 | C12orf54 | C12orf56 | C12orf57 | C12orf60 | C12orf74 | C12orf75 | C12orf76 | C13orf42 | C13orf46 | C14orf119 | C14orf132 | C14orf178 | C14orf180 | C14orf28 | C14orf39 | C14orf93 | C15orf32 | C15orf39 | C15orf40 | C15orf48